POMC and COVID-19: Although it is yet to be found which peptide has ACTH mimicry, it has been observed that critically ill patients with COVID-19 have elevated titers of anti-ACTH antibodies, suggesting a possible explanation for the adrenocorticotropic impairment that is associated with SARS-CoV-2 infections (40, 41).